Characterization of gram-negative bloodstream infections in hospitalised Australian children and their clinical outcomes

Sophie CH Wen,Patrick N A Harris,Brian Forde,Budi Permana,Mark D Chatfield,Colleen L Lau,Geoffrey Spurling,Michelle J Bauer,Ross Balch,Henry Chambers,Luregn J Schlapbach,Julia E Clark,Sonia Dougherty,Christopher C Blyth,Philip N Britton,Vanessa Clifford,Gabrielle M Haeusler,Brendan McMullan,Ushma Wadia,David L Paterson,Adam D Irwin,Jeremy Carr,Nan Vasilunas,Joshua R Francis,Kristine Macartney,Nigel W Crawford,Nicholas Wood,Jim Buttery,Helen Marshall,Elizabeth Elliott,Peter Richmond,Emma Carey,Alissa McMinn,Karen Bellamy,Guillian Hunter,Kathryn Meredith,Laura Rost,Nicole Kerly,Sara Cook,Natasha Doran,Laura Francis,Christine Heath,Carolyn Finucane,Mehyar Khair Baik,Laura Lopez,Catherine Glover,the PAEDS network

DOI: https://doi.org/10.1093/cid/ciae341

IF: 20.999

2024-06-27

Clinical Infectious Diseases

Abstract:Gram-negative bloodstream infections (GNBSI) more commonly occur in children with comorbidities and are increasingly associated with antimicrobial resistance. There are few large studies of GNBSI in children that relate the clinical presentation, pathogen characteristics and outcomes. A 3-year prospective study of GNBSI in children aged <18 years was conducted in five Australian children's hospitals between 2019-2021. The clinical characteristics, disease severity and outcomes were recorded. Causative pathogens underwent antibiotic susceptibility testing and whole genome sequencing. There were 931 GNBSI episodes involving 818 children. Median age was 3 years (IQR 0.6-8.5). 576/931 episodes (62%) were community onset though 661/931 (71%) occurred in children with comorbidities and a central venous catheter (CVC) was present in 558/931 (60%). CVC (145/931) and urinary tract (149/931) were the most common sources (16% each). 100/931 (11%) children required Intensive Care Unit (ICU) admission and a further 11% (105/931) developed GNBSI in ICU. 659/927 (71%) isolates were Enterobacterales of which 22% (138/630) were third generation cephalosporin resistant (3GCR). Extended spectrum beta-lactamase genes (ESBL) were confirmed in 65/138 (47%) 3GCR-Enterobacterales. Most common ESBL genes were bla CTX-M-15 (34/94, 36%) and bla SHV-12 (10/94, 11%). There were 48 deaths overall and 30-day in-hospital mortality was 3% (32/931). Infections with 3GCR Enterobacterales were independently associated with higher mortality (adjusted OR 3.2, 95%CI 1.6-6.4). GNBSI in children are frequently healthcare-associated and affect children under 5 years. Infections with 3GCR Enterobacterales were associated with worse outcomes. These findings will inform optimal management guidelines and help prioritise future antimicrobial clinical trials. This graphical abstract is also available at Tidbit: https://tidbitapp.io/institutional-portal/clinical-infectious-diseases/tidbits/characterization-of-gram-negative-bloodstream-infections-in-hospitalised-australian-children-and-their-clinical-outcomes/update

immunology,infectious diseases,microbiology

What problem does this paper attempt to address?

The paper attempts to address the clinical characteristics, pathogen properties, and clinical outcomes of Gram-negative bloodstream infections (GNBSI) in children. Specifically, the study aims to systematically describe the pathogen characteristics of GNBSI in hospitalized children in Australia and identify risk factors associated with adverse outcomes. The study found that GNBSI caused by 3rd generation cephalosporin-resistant Enterobacterales (3GCR Enterobacterales) is associated with higher mortality rates. These findings contribute to the development of better management guidelines and inform the design of future clinical trials for antimicrobial agents. Additionally, the study highlights the urgency of conducting antibiotic clinical trials in neonates and children to address the growing issue of antimicrobial resistance and the limited options for effective antibiotics.